Tag:
Benicar
Latest Headlines
Latest Headlines
Drug prices steam ahead at record pace
Despite the best efforts of private and public payers, the price of top-selling medicines in the U.S. bubbled up 6.9 percent last year--the fastest rate of growth for the past decade. Barclays
FDA, Lancet raise ARB safety questions
Blood pressure meds are in the safety spotlight today. FDA is looking into whether Daiichi Sankyo's angiotensin-receptor blocker Benicar increases the risk of heart-related death, while new data in
